Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Appyea Inc
(OP:
APYP
)
0.0218
UNCHANGED
Streaming Delayed Price
Updated: 3:12 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Appyea Inc
AppYea Launches E-Commerce Store on Amazon Broadening Distribution
March 20, 2024
Via
ACCESSWIRE
AppYea Enters Commercial Phase with First Deliveries of AppySleep to Customers in the U.S.
January 10, 2024
Via
ACCESSWIRE
AppYea Provides Year-End Letter to Shareholders Recapping Key Achievements and Sharing Outlook for 2024
December 13, 2023
Via
ACCESSWIRE
AppYea Secures US Patent for Innovative Sleep Apnea Detection Using Speech Analysis
August 28, 2023
Via
ACCESSWIRE
AppYea Announces Equity Financing Transaction to Accelerate Commercial Launch
August 03, 2023
Via
ACCESSWIRE
AppYea Announces Appointment of Leading Medical Device Industry Executive Adi Shemer as CEO
July 31, 2023
Via
ACCESSWIRE
Leading Operations Executive Adi Shemer Joins AppYea's Advisory Board
February 16, 2023
Via
ACCESSWIRE
Ron Mekler Joins AppYea's Board of Directors Audit Committee Chair
January 23, 2023
Via
ACCESSWIRE
SleepX has Started Marketing its Flagship Product, DreamIT - an AI-Based Wristband to Treat the Snoring Problem Through Biofeedback
November 29, 2022
Via
ACCESSWIRE
First version of the SleepX APP has been uploaded to the Google Play Store
July 07, 2022
SleepX, a subsidiary of AppYea (OTC: APYP) a Company that is focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, announces that the first version of...
Via
TheNewswire.com
SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application
May 31, 2022
SleepX, a subsidiary of AppYea (OTC: APYP) focusing on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, announces it received approval from the Helsinki...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
AppYea expands its SleepX patent commercialization portfolio with a non-diluting agreement.
May 16, 2022
AppYea (OTC: APYP) announced that its subsidiary SleepX, which focuses on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring – has signed new commercialization...
Via
TheNewswire.com
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
Vinergy Appoints Todd Violette as CEO and Director to Drive Focus on Blockchain & Bitcoin Growth Opportunities
April 20, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2021) - Vinergy Capital, Inc. (CSE: VIN) (OTCQB: VNNYF) (FSE: 1V70) ("Vinergy" or the...
Via
Newsfile
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.